When compared to subjects with WFA+-M2BP ≥ 1.0 and those with WFA+-M2BP < 1.0, albumin levels and platelet counts were significantly lower in subjects with WFA+-M2BP ≥ 1.0, and the presence of diabetes mellitus was significantly higher in subjects with WFA+-M2BP ≥ 1.0. This evidence concerns the gene ALB and diabetes mellitus.